☆ 4.8 Article

Microfluidics-enabled Serial Assembly of Lipid-siRNA-sorafenib Nanoparticles for Synergetic Hepatocellular Carcinoma Therapy

ADVANCED MATERIALS (2023)

Related references

Note: Only part of the references are listed.

Article Chemistry, Multidisciplinary

Microfluidic technologies and devices for lipid nanoparticle-based RNA delivery

Masatoshi Maeki et al.

Summary: mRNA vaccines have been approved for COVID-19 prevention, thanks to the development of RNA-delivery technology such as lipid nanoparticles (LNPs). Recently, microfluidic devices and technologies have been utilized for the production of RNA-loaded LNPs, providing advantages such as precise control over LNP size, reproducibility, and high-throughput optimization.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Preclinical development and phase 1 trial of a novel siRNA targeting lipoprotein(a)

Michael J. Koren et al.

Summary: This study reports the discovery and development of a new drug, olpasiran, which can directly inhibit the translation of Lp(a) messenger RNA, leading to a significant reduction in plasma Lp(a) concentration. In animal and human trials, olpasiran demonstrated good safety and tolerability, and maintained a sustained reduction in high plasma Lp(a) concentration.

NATURE MEDICINE (2022)

Add to Collection

Article Multidisciplinary Sciences

Fasting improves therapeutic response in hepatocellular carcinoma through p53-dependent metabolic synergism

Jelena Krstic et al.

Summary: Fasting improves the efficacy of sorafenib and sensitizes sorafenib-resistant HCC by preventing the Warburg shift through reduction in glucose and AKT/mTOR signaling. p53 is necessary for the sorafenib-sensitizing effect of fasting.

SCIENCE ADVANCES (2022)

Add to Collection

Article Multidisciplinary Sciences

Thermostable ionizable lipid-like nanoparticle (iLAND) for RNAi treatment of hyperlipidemia

Bo Hu et al.

Summary: A series of ionizable lipid-like materials were designed to develop a thermostable siRNA delivery system. The optimized formulation showed dose and time dual-dependent gene silencing and effectively reduced serum cholesterol and triglyceride levels. This research holds significant value for the treatment of hyperlipidemia and prevention of metabolic diseases.

SCIENCE ADVANCES (2022)

Add to Collection

Article Chemistry, Multidisciplinary

Targeted Drug/Gene/Photodynamic Therapy via a Stimuli-Responsive Dendritic-Polymer-Based Nanococktail for Treatment of EGFR-TKI-Resistant Non-Small-Cell Lung Cancer

Jinxing Huang et al.

Summary: This study proposes a nanococktail therapeutic strategy for treating EGFR-TKI resistant NSCLC by targeted co-delivery of drugs and genes, along with photodynamic therapy. The results show that this nanococktail therapy effectively releases drugs and genes at the tumor site, demonstrating potent antitumor efficacy.

ADVANCED MATERIALS (2022)

Add to Collection

Article Biochemistry & Molecular Biology

Molecular correlates of clinical response and resistance to atezolizumab in combination with bevacizumab in advanced hepatocellular carcinoma

Andrew X. Zhu et al.

Summary: This study analyzed tumor samples from patients with hepatocellular carcinoma and found that combination therapy with atezolizumab and bevacizumab was effective in treating this type of cancer. Patients with high expression of VEGF Receptor 2, regulatory T cells, and myeloid inflammation signatures showed better outcomes with the combination therapy compared to atezolizumab alone. These findings provide insights into baseline immune and genetic features that can identify patients who will benefit from the combination therapy of atezolizumab and bevacizumab in advanced hepatocellular carcinoma.

NATURE MEDICINE (2022)

Add to Collection

Review Oncology

Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer

Marilyne Labrie et al.

Summary: Normal and cancer cells utilize adaptive responses to survive environmental stresses, and this Review discusses how tumor ecosystems adapt to therapeutic stresses and how these adaptations can be exploited to overcome cancer therapy resistance.

NATURE REVIEWS CANCER (2022)

Add to Collection

Review Pharmacology & Pharmacy

Synthetic multi-layer nanoparticles for CRISPR-Cas9 genome editing

Hao Tang et al.

Summary: CRISPR holds great potential in biomedical research and disease therapy but faces challenges in efficient delivery. Various multi-layered non-viral vectors have been developed for CRISPR delivery, with ongoing clinical trials to test their efficacy.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Ultra-small lipid nanoparticles encapsulating sorafenib and midkine-siRNA selectively-eradicate sorafenib-resistant hepatocellular carcinoma in vivo

Mahmoud A. Younis et al.

Summary: The usLNPs, composed of a novel pH-sensitive lipid, phospholipids, and a targeting peptide, demonstrated enhanced tumor accumulation, selectivity, and in vivo gene silencing. This combination therapy synergistically eradicated HCC in mice at a low dose of SOR and showed promising potential for clinical applications.

JOURNAL OF CONTROLLED RELEASE (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Self-Activated Cascade-Responsive Sorafenib and USP22 shRNA Co-Delivery System for Synergetic Hepatocellular Carcinoma Therapy

Shengjun Xu et al.

Summary: Resistance to sorafenib in hepatocellular carcinoma is closely linked to cancer stemness, with the lack of effective methods to reverse this stemness being a major obstacle in current HCC therapeutics. The development of Gal-SLPs, which target HCC and co-deliver sorafenib and shUSP22, shows promising results in suppressing USP22 expression, inhibiting multidrug resistance, and efficiently inhibiting HCC cell viability and proliferation. In vivo studies using a sorafenib-insensitive patient-derived xenograft model demonstrate potent antitumor effects and biosafety of Gal-SLPs, suggesting their potential in clinical HCC treatment.

ADVANCED SCIENCE (2021)

Add to Collection

Article Medicine, General & Internal

Hepatocellular carcinoma

Josep M. Llovet et al.

Summary: Liver cancer, particularly hepatocellular carcinoma (HCC), poses a significant global health challenge with rising incidence projected to exceed 1 million cases by 2025. Infection by hepatitis B and C viruses remains a major risk factor for HCC, while non-alcoholic steatohepatitis is emerging as a more common risk factor in Western countries. Advances in systemic therapies for HCC, including immunotherapies and targeted therapies, are expected to revolutionize the management of this disease.

NATURE REVIEWS DISEASE PRIMERS (2021)

Add to Collection

Article Nanoscience & Nanotechnology

Immunostimulant hydrogel for the inhibition of malignant glioma relapse post-resection

Jing Zhang et al.

Summary: The study introduces an injectable hydrogel system that stimulates tumoricidal immunity after GBM surgical resection, effectively reducing its recurrence. This system induces immunogenic cell death and sustained T-cell infiltration to attack residual tumor cells, significantly suppressing postoperative GBM recurrence.

NATURE NANOTECHNOLOGY (2021)

Add to Collection

Review Nanoscience & Nanotechnology

Multifunctional biomolecule nanostructures for cancer therapy

Jing Wang et al.

Summary: This review discusses the application of biomolecule-based nanostructures in smart cancer nanomedicine. These multifunctional nanostructures, including polysaccharides, nucleic acids, peptides, and proteins, can achieve targeted drug delivery and transport drugs to tumor tissues.

NATURE REVIEWS MATERIALS (2021)

Add to Collection

Review Engineering, Biomedical

Microfluidic formulation of nanoparticles for biomedical applications

Sarah J. Shepherd et al.

Summary: Nanomedicine has advanced significantly in clinical applications, with microfluidic devices showing potential for generating reproducible nanoparticle formulations. These formulations enhance biomedical applications with controlled physical properties, pointing towards future production scale-independent formulations through parallelization and multi-step reactions.

BIOMATERIALS (2021)

Add to Collection

Article Multidisciplinary Sciences

EGFR activation limits the response of liver cancer to lenvatinib

Haojie Jin et al.

Summary: Inhibition of EGFR is synthetically lethal with lenvatinib in liver cancer, and the combination of lenvatinib with the EGFR inhibitor gefitinib shows potent anti-proliferative effects both in vitro and in vivo. This combination therapy could be a promising strategy for HCC patients with high levels of EGFR, providing meaningful clinical responses.

NATURE (2021)

Add to Collection

Article Immunology

Development of an mRNA-LNP Vaccine against SARS-CoV-2: Evaluation of Immune Response in Mouse and Rhesus Macaque

Alireza Naderi Sohi et al.

Summary: Among vaccines developed against SARS-CoV-2, mRNA-based vaccines have shown promising safety and efficacy. The study evaluated a mRNA-LNP vaccine with modified mRNA and lipid nanoparticles, demonstrating significant immune response induction against SARS-CoV-2.

VACCINES (2021)

Add to Collection

Article Chemistry, Multidisciplinary

Theranostic Layer-by-Layer Nanoparticles for Simultaneous Tumor Detection and Gene Silencing

Natalie Boehnke et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Add to Collection

Article Oncology

Simvastatin re-sensitizes hepatocellular carcinoma cells to sorafenib by inhibiting HIF-1α/PPAR-γ/PKM2-mediated glycolysis

Jiao Feng et al.

JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2020)

Add to Collection

Article Cell Biology

Low-Dose Sorafenib Acts as a Mitochondrial Uncoupler and Ameliorates Nonalcoholic Steatohepatitis

Chongshu Jian et al.

CELL METABOLISM (2020)

Add to Collection

Article Chemistry, Multidisciplinary

A programmable polymer library that enables the construction of stimuli-responsive nanocarriers containing logic gates

Penghui Zhang et al.

NATURE CHEMISTRY (2020)

Add to Collection

Article Multidisciplinary Sciences

Co-delivery of IKBKE siRNA and cabazitaxel by hybrid nanocomplex inhibits invasiveness and growth of triple-negative breast cancer

Zhen Zhao et al.

SCIENCE ADVANCES (2020)

Add to Collection

Article Chemistry, Multidisciplinary

Sub-10 nm Aggregation-Induced Emission Quantum Dots Assembled by Microfluidics for Enhanced Tumor Targeting and Reduced Retention in the Liver

Xuanyu Li et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2020)

Add to Collection

Review Biochemistry & Molecular Biology

The mechanisms of sorafenib resistance in hepatocellular carcinoma: theoretical basis and therapeutic aspects

Weiwei Tang et al.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2020)

Add to Collection

Article Nanoscience & Nanotechnology

Precise targeting of POLR2A as a therapeutic strategy for human triple negative breast cancer

Jiangsheng Xu et al.

NATURE NANOTECHNOLOGY (2019)

Add to Collection

Article Chemistry, Physical

Targeted homology-directed repair in blood stem and progenitor cells with CRISPR nanoformulations

Reza Shahbazi et al.

NATURE MATERIALS (2019)

Add to Collection

Review Chemistry, Multidisciplinary

Rekindling RNAi Therapy: Materials Design Requirements for In Vivo siRNA Delivery

Byungji Kim et al.

ADVANCED MATERIALS (2019)

Add to Collection

Article Oncology

HIF-1 alpha-induced RIT1 promotes liver cancer growth and metastasis and its deficiency increases sensitivity to sorafenib

Zhen Song et al.

CANCER LETTERS (2019)

Add to Collection

Article Medicine, Research & Experimental

A Multifunctional Lipid-Based Nanodevice for the Highly Specific Codelivery of Sorafenib and Midkine siRNA to Hepatic Cancer Cells

Mahmoud A. Younis et al.

MOLECULAR PHARMACEUTICS (2019)

Add to Collection

Article Multidisciplinary Sciences

Genome-wide CRISPR/Cas9 library screening identified PHGDH as a critical driver for Sorafenib resistance in HCC

Lai Wei et al.

NATURE COMMUNICATIONS (2019)

Add to Collection

Article Chemistry, Multidisciplinary

Binary Targeting of siRNA to Hematologic Cancer Cells In Vivo Using Layer-by-Layer Nanoparticles

Ki Young Choi et al.

ADVANCED FUNCTIONAL MATERIALS (2019)

Add to Collection

Article Oncology

Evaluation of a locked nucleic acid form of antisense oligo targeting HIF-1α in advanced hepatocellular carcinoma

Jennifer Wu et al.

WORLD JOURNAL OF CLINICAL ONCOLOGY (2019)

Add to Collection

Review Pharmacology & Pharmacy

Microfluidics for producing poly (lactic-co-glycolic acid)-based Check for pharmaceutical nanoparticles

Xuanyu Li et al.

ADVANCED DRUG DELIVERY REVIEWS (2018)

Add to Collection

Article Pharmacology & Pharmacy

Co-delivery of sorafenib and siVEGF based on mesoporous silica nanoparticles for ASGPR mediated targeted HCC therapy

Guirong Zheng et al.

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2018)

Add to Collection

Article Medicine, General & Internal

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Masatoshi Kudo et al.

LANCET (2018)

Add to Collection

Review Oncology

Molecular therapies and precision medicine for hepatocellular carcinoma

Josep M. Llovet et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2018)

Add to Collection

Article Multidisciplinary Sciences

Reversal of pancreatic desmoplasia by re-educating stellate cells with a tumour microenvironment-activated nanosystem

Xuexiang Han et al.

NATURE COMMUNICATIONS (2018)

Add to Collection

Review Biochemistry & Molecular Biology

Sorafenib resistance in hepatocarcinoma: role of hypoxia-inducible factors

Carolina Mendez-Blanco et al.

EXPERIMENTAL AND MOLECULAR MEDICINE (2018)

Add to Collection

Article Chemistry, Multidisciplinary

One-Step Microfluidic Synthesis of Nanocomplex with Tunable Rigidity and Acid-Switchable Surface Charge for Overcoming Drug Resistance

Qiang Feng et al.

SMALL (2017)

Add to Collection

Article Nanoscience & Nanotechnology

In situ programming of leukaemia-specific T cells using synthetic DNA nanocarriers

Tyrel T. Smith et al.

NATURE NANOTECHNOLOGY (2017)

Add to Collection

Article Chemistry, Multidisciplinary

Microfluidic Manipulation of Core/Shell Nanoparticles for Oral Delivery of Chemotherapeutics: A New Treatment Approach for Colorectal Cancer

Mohammad Mahdi Hasani-Sadrabadi et al.

ADVANCED MATERIALS (2016)

Add to Collection

Article Gastroenterology & Hepatology

ADRB2 signaling promotes HCC progression and sorafenib resistance by inhibiting autophagic degradation of HIF1α

Fu-Quan Wu et al.

JOURNAL OF HEPATOLOGY (2016)

Add to Collection

Article Chemistry, Multidisciplinary

Microfluidic Synthesis of Rigid Nanovesicles for Hydrophilic Reagents Delivery

Lu Zhang et al.

ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2015)

Add to Collection

Review Genetics & Heredity

Knocking down disease: a progress report on siRNA therapeutics

Anders Wittrup et al.

NATURE REVIEWS GENETICS (2015)

Add to Collection

Article Medicine, Research & Experimental

Simultaneous Inhibition of Tumor Growth and Angiogenesis for Resistant Hepatocellular Carcinoma by Co-delivery of Sorafenib and Survivin Small Hairpin RNA

Jianan Shen et al.

MOLECULAR PHARMACEUTICS (2014)

Add to Collection

Article Biochemistry & Molecular Biology

In vivo RNAi screening identifies a mechanism of sorafenib resistance in liver cancer

Ramona Rudalska et al.

NATURE MEDICINE (2014)

Add to Collection

Article Gastroenterology & Hepatology

Hypoxia-Mediated Sorafenib Resistance Can Be Overcome by EF24 Through Von Hippel-Lindau Tumor Suppressor-Dependent HIF-1α Inhibition in Hepatocellular Carcinoma

Yingjian Liang et al.

HEPATOLOGY (2013)

Add to Collection

Article Nanoscience & Nanotechnology

Electrostatic assembly of binary nanoparticle superlattices using protein cages

Mauri A. Kostiainen et al.

NATURE NANOTECHNOLOGY (2013)

Add to Collection

Review Chemistry, Multidisciplinary

Co-delivery of siRNA and therapeutic agents using nanocarriers to overcome cancer resistance

Mar Creixell et al.

NANO TODAY (2012)

Add to Collection

Review Nanoscience & Nanotechnology

Microfluidic technologies for accelerating the clinical translation of nanoparticles

Pedro M. Valencia et al.

NATURE NANOTECHNOLOGY (2012)

Add to Collection

Review Pharmacology & Pharmacy

Hypoxia-inducible factors: mediators of cancer progression and targets for cancer therapy

Gregg L. Semenza

TRENDS IN PHARMACOLOGICAL SCIENCES (2012)

Add to Collection

Article Pharmacology & Pharmacy

Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells

Luigi Fiume et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2011)

Add to Collection

Article Nanoscience & Nanotechnology

Electrostatic focusing of unlabelled DNA into nanoscale pores using a salt gradient

Meni Wanunu et al.

NATURE NANOTECHNOLOGY (2010)

Add to Collection

Article Oncology

A RNA antagonist of hypoxia-inducible factor-1α, EZN-2968, inhibits tumor cell growth

Lee M. Greenberger et al.

MOLECULAR CANCER THERAPEUTICS (2008)

Add to Collection

Review Oncology

Targeting HIF-1 for cancer therapy

GL Semenza

NATURE REVIEWS CANCER (2003)

Add to Collection

© Peeref 2019-2024. All rights reserved.